Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007552:Isotonic Solutions / Q000627:therapeutic use; D018375:Neutrophil Activation / Q000187:drug effects / Q000502:physiology; D009504:Neutrophils / Q000276:immunology; D009569:Nitric Oxide / Q000378:metabolism; D010431:Pentoxifylline / Q000494:pharmacology / Q000627:therapeutic use*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D012151:Resuscitation; D000077325:Ringer's Lactate; D012771:Shock, Hemorrhagic / Q000503:physiopathology*; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology
D000276:Adjuvants, Immunologic; D016207:Cytokines; D007552:Isotonic Solutions; D010726:Phosphodiesterase Inhibitors; D000077325:Ringer's Lactate; D009569:Nitric Oxide; D010431:Pentoxifylline